Dimensional Fund Advisors Reports 5.5% Stake in Pediatrix Medical

TL;DR

**Dimensional Fund Advisors just revealed a 5.5% stake in Pediatrix, a bullish signal from a big player.**

AI Summary

Dimensional Fund Advisors LP, a major investment firm, reported on February 9, 2024, that it holds 4,683,927 shares of Pediatrix Medical Group Inc. (formerly MEDNAX, Inc.) common stock, representing 5.5% of the company. This filing, triggered by an event on December 29, 2023, indicates that Dimensional Fund Advisors LP is a significant passive investor in Pediatrix, signaling their belief in the company's long-term prospects. For current or prospective shareholders, this means a large institutional investor sees value in Pediatrix, which can provide a level of confidence, but also means a substantial block of shares is held by a single entity.

Why It Matters

This filing shows a major institutional investor, Dimensional Fund Advisors LP, has taken a significant passive stake in Pediatrix Medical Group, which can be seen as a vote of confidence in the company's future.

Risk Assessment

Risk Level: low — This filing indicates a passive investment by a large fund, which generally doesn't pose an immediate risk to the company or its stock price.

Analyst Insight

A smart investor would view this as a positive signal, indicating institutional confidence in Pediatrix Medical Group. It might warrant further research into Pediatrix's fundamentals, as a large, passive institutional stake often suggests a belief in long-term value.

Key Numbers

• 4,683,927 — Shares Owned (Represents the total number of common stock shares of Pediatrix Medical Group Inc. beneficially owned by Dimensional Fund Advisors LP.)
• 5.5% — Ownership Percentage (Indicates the percentage of Pediatrix Medical Group Inc.'s common stock owned by Dimensional Fund Advisors LP, making them a significant shareholder.)
• December 29, 2023 — Event Date (The specific date when Dimensional Fund Advisors LP's ownership crossed the threshold requiring this SC 13G filing.)

Key Players & Entities

• Dimensional Fund Advisors LP (company) — the reporting person and institutional investor
• Pediatrix Medical Group Inc. (company) — the subject company whose shares are being reported
• MEDNAX, INC. (company) — former name of Pediatrix Medical Group Inc.
• 4,683,927 (dollar_amount) — number of shares beneficially owned by Dimensional Fund Advisors LP
• 5.5% (dollar_amount) — percentage of class beneficially owned by Dimensional Fund Advisors LP
• December 29, 2023 (person) — date of event requiring the filing
• February 9, 2024 (person) — date the SC 13G filing was made

Forward-Looking Statements

• Dimensional Fund Advisors LP will maintain or slightly increase its passive stake in Pediatrix Medical Group Inc. over the next year. (Dimensional Fund Advisors LP) — medium confidence, target: February 9, 2025

FAQ

Filing Documents

• SEC13G_Filing.htm (SC 13G) — 17KB
• 0000354204-24-003013.txt ( ) — 19KB

From the Filing

SC 13G 1 SEC13G_Filing.htm SEC SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. _ ) * Pediatrix Medical Group Inc (Name of Issuer) Common Stock (Title of Class of Securities) 58502B106 (CUSIP Number) December 29, 2023 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [X] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) * The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 (the "Act") or otherwise subject to the liabilities of that section of the Act, but shall be subject to all other provisions of the Act (however, see the Notes.) CUSIP No. 58502B106 1. NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY) Dimensional Fund Advisors LP 30-0447847 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [ ] (b) [X] 3. SEC USE ONLY 4. CITIZENSHIP OR PLACE OF ORGANIZATION Delaware Limited Partnership NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5. SOLE VOTING POWER 4,311,030 ** see Note 1 ** 6. SHARED VOTING POWER 0 7. SOLE DISPOSITIVE POWER 4,409,901 ** see Note 1 ** 8. SHARED DISPOSITIVE POWER 0 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 4,409,901 ** see Note 1 ** 10. CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES [ ] 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 5.2% 12. TYPE OF REPORTING PERSON IA Item 1. (a) Name of Issuer Pediatrix Medical Group Inc (b) Address of Issuer's Principal Executive Offices 1301 Concord Terrace, Sunrise, FL 33323 Item 2. (a) Name of Person Filing Dimensional Fund Advisors LP (b) Address of Principal Business Office or, if None, Residence 6300 Bee Cave Road, Building One, Austin, TX 78746 (c) Citizenship Delaware Limited Partnership (d) Title of Class of Securities Common Stock (e) CUSIP Number 58502B106 Item 3. If This Statement is Filed Pursuant to Rule 13d-1(b), or 13d-2(b) or (c), Check Whether the Person Filing is a: (a) [ ] Broker or dealer registered under Section 15 of the Act (15 U.S.C. 78o). (b) [ ] Bank as defined in Section 3(a)(6) of the Act (15 U.S.C. 78c). (c) [ ] Insurance Company as defined in Section 3(a)(19) of the Act (15 U.S.C. 78c). (d) [ ] Investment Company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8). (e) [X] An investment adviser in accordance with Rule 240.13d-1(b)(1)(ii)(E); (f) [ ] An employee benefit plan or endowment fund in accordance with Rule 240.13d-1(b)(1)(ii)(F); (g) [ ] A parent holding company or control person in accordance with Rule 240.13d-1(b)(1)(ii)(G); (h) [ ] A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); (i) [ ] A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3); (j) [ ] Group, in accordance with Rule 240.13d-1(b)(1)(ii)(J). Item 4. Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1. (a) Amount Beneficially Owned: 4,409,901 ** see Note 1 ** (b) Percent of Class: 5.2% (c) Number of shares as to which such person has: (i) sole power to vote or to direct the vote 4,311,030 ** see Note 1 ** (ii) shared power to vote or to direct the vote 0 (iii) sole power to dispose or to direct the disposition of 4,409,901 ** see Note 1 ** (iv) shared power to dispose or to direct the disposition of 0 ** Note 1 ** Dimensional Fund Advisors LP, an investment adviser registered under Section 203 of the Investment Advisors Act of 1940, furnishes investment advice to four investment companies registered under the Investment Company Act of 1940, and serves as investment manager or sub-adviser to certain other commingled funds, group trusts and separate accounts (such investment companies, trusts and accounts, collectively referred to as the "Funds"). In certain cases, subsidiaries of Dimensional Fund Advisors LP may act as an adviser or sub-adviser to certain Funds. In its role as investment advisor, sub-adviser and/or manager, Dimensional Fund Advisors LP or its subsidiaries (collectively, "Dimensional") may possess voting and/or investment power over the securities of the Issuer that are owned by the Funds, and may be deemed to be the

View Full Filing

View this SC 13G filing on SEC EDGAR